Conditions: Arthritis, Rheumatoid
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 77
Healthy volunteers: no

Brief summary:
This is an open-label, phase II study of BI 695501 to assess handling experience of patients with Rheumatoid Arthritis using an autoinjector. The extension phase is to provide patients with additional exposure to BI 695501 and to enhance the safety database for this compound.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: BI 695501 Autoinjector intervention 2: BI 695501 Prefilled syringe
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: